Platelet × CRP Multiplier Value as an Indicator of Poor Prognosis in Patients With Resectable Pancreatic Cancer

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Pancreas

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MPA.0000000000000697PMID 27984485
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A new preoperative prognostic scoring system to predict prognosis in patients with locally advanced pancreatic body cancer who undergo distal pancreatectomy with en bloc celiac axis resection: a retrospective cohort study.

  2014cited by this paper
• The pretreatment platelet and plasma fibrinogen level correlate with tumor progression and metastasis in patients with pancreatic cancer

  2014cited by this paper
• S-1 in the treatment of pancreatic cancer.

  2014cited by this paper
• The platelet-cancer loop.

  2013cited by this paper
• Thrombocytosis before pre-operative chemoradiotherapy predicts poor response and shorter local recurrence-free survival in rectal cancer

  2013cited by this paper
• Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.

  2013cited by this paper
• The Analysis of Survival Data

  2012cited by this paper
• Coagulation activation and microparticle-associated coagulant activity in cancer patients

  2012cited by this paper
• Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials.

  2012cited by this paper
• Paraneoplastic thrombocytosis in ovarian cancer.

  2012cited by this paper
• Impact of pretreatment thrombocytosis on blood-borne metastasis and prognosis of gastric cancer.

  2012cited by this paper
• The prognostic value of thrombocytosis in newly diagnosed lung cancer patients: a retrospective analysis.

  2011cited by this paper
• Impact of Operative Blood Loss on Survival in Invasive Ductal Adenocarcinoma of the Pancreas

  2011cited by this paper
• Perioperative blood transfusions promote pancreas cancer progression.

  2011cited by this paper
• Nutritional predictors of postoperative outcome in pancreatic cancer

  2011cited by this paper
• Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio.

  2010cited by this paper
• Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma.

  2009cited by this paper
• New Insights Into Cancer-Associated Thrombosis

  2009cited by this paper
• Obesity and risk of pancreatic cancer among postmenopausal women: the Women's Health Initiative (United States)

  2008cited by this paper
• Randomized phase III trial of adjuvant chemotherapy with gemcitabine versus S-1 in patients with resected pancreatic cancer: Japan Adjuvant Study Group of Pancreatic Cancer (JASPAC-01).

  2008cited by this paper
• Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer

  2008cited by this paper
• Cancer Statistics, 2007

  2007cited by this paper
• Trousseau's syndrome: multiple definitions and multiple mechanisms.

  2007cited by this paper
• The Ratio of Metastatic/Resected Lymph Nodes is an Independent Prognostic Factor in Patients With Node-positive Pancreatic Head Cancer

  2006cited by this paper
• Consistent liver metastases in a rat model by portal injection of microencapsulated cancer cells.

  2006cited by this paper
• Decreased Total Lymphocyte Counts in Pancreatic Cancer: An Index of Adverse Outcome

  2006cited by this paper
• Influence of Surgical Resection and Post-Operative Complications on Survival following Adjuvant Treatment for Pancreatic Cancer in the ESPAC-1 Randomized Controlled Trial

  2006cited by this paper
• Postoperative pancreatic fistula: an international study group (ISGPF) definition.

  2005cited by this paper
• Increased preoperative platelet count is associated with decreased survival after resection for adenocarcinoma of the pancreas.

  2005cited by this paper
• Malignancies, prothrombotic mutations, and the risk of venous thrombosis.

  2005cited by this paper
• Platelets counts closely correlate with the disease-free survival interval of pancreatic cancer patients.

  2004cited by this paper
• Systemic inflammatory response predicts outcome in patients undergoing resection for ductal adenocarcinoma head of pancreas

  2004cited by this paper
• Prognostic Factors Following Curative Resection for Pancreatic Adenocarcinoma: A Population-Based, Linked Database Analysis of 396 Patients

  2003cited by this paper
• Platelets and cancer.

  2002cited by this paper
• The role of C-reactive protein as a prognostic indicator in advanced cancer

  2002cited by this paper
• Preoperative platelet count predicts survival after resection of periampullary adenocarcinoma.

  2001cited by this paper
• Platelet counts and prognosis of pancreatic cancer.

  1999cited by this paper
• Venous thromboembolism and cancer.

  1998cited by this paper
• Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

  1997cited by this paper
• Receiver operating characteristic (ROC) methodology: the state of the art.

  1989cited by this paper
• Adjuvant antiplatelet therapy with aspirin in colo-rectal cancer.

  1982cited by this paper
• Use of inhibitors of prostaglandin synthesis in patients with breast cancer.

  1980cited by this paper
• Thrombocytosis: platelet kinetics in neoplasia.

  1974cited by this paper
• Antimetastatic effects associated with platelet reduction.

  1968cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper
• Phlegmasia alba dolens.

  year unknowncited by this paper

• Prognostic value of the C-reactive protein-albumin-lymphocyte index in cancer patients with sarcopenia: A study on overall survival.

  2025cites this paper
• Perioperative Platelet Count Ratio Predicts Long-Term Survival after Left Pancreatectomy and Splenectomy for Pancreatic Adenocarcinoma

  2024cites this paper
• Clinical usefulness of C-reactive protein-albumin-lymphocyte (CALLY) index as a prognostic biomarker in patients undergoing surgical resection of pancreatic cancer

  2024cites this paper
• A randomized phase II study of full dose gemcitabine versus reduced dose gemcitabine and nab-paclitaxel in vulnerable patients with non-resectable pancreatic cancer (DPCG-01)

  2023cites this paper
• Taiwan Society of Colon and Rectum Surgeons (TSCRS) Consensus for Anti-Inflammatory Nutritional Intervention in Colorectal Cancer

  2022cites this paper
• Pancreatic ductal adenocarcinoma: Prognostic indicators of advanced disease

  2022cites this paper
• High platelet × C-reactive protein level multiplier is a negative prognostic marker in rectal cancer treated by neoadjuvant chemoradiotherapy

  2021cites this paper
• Platelet infiltration predicts survival in postsurgical colorectal cancer patients

  2021cites this paper
• Diagnosis and Management of Pancreatic Exocrine Insufficiency in Pancreatic Cancer

  2021cites this paper
• Pancreatic ductal adenocarcinoma and distal cholangiocarcinoma: a proposal of preoperative diagnostic score for differential diagnosis

  2021cites this paper
• Reduced mean platelet volume levels predict shorter survival in patients with resectable pancreatic ductal adenocarcinoma and type 2 diabetes

  2020cites this paper
• Prognostic Value of the C-Reactive Protein/Lymphocyte Ratio in Pancreatic Cancer

  2020cites this paper
• Understanding pancreatic exocrine insufficiency and replacement therapy in pancreatic cancer.

  2020cites this paper
• Chemotherapy-Induced Reduction of Neutrophil-to-Lymphocyte Ratio Is Associated With Better Survival in Pancreatic Adenocarcinoma: A Meta-Analysis

  2020cites this paper
• Remnant pancreatic volume as an indicator of poor prognosis in pancreatic cancer patients after resection.

  2019cites this paper
• Prognostic significance of platelet × C-reactive protein multiplier in patients with esophageal squamous cell carcinoma

  2019cites this paper
• CA19–9 decrease and survival according to platelet level in patients with advanced pancreatic cancer

  2019cites this paper
• Invasive Ductal Carcinoma Arising in Mucinous Cystic Neoplasm of Pancreas: A Case Report

  2019cites this paper
• A novel approach of platelet function test for prediction of attenuated response to clopidogrel

  2019cites this paper
• The prognostic significance of the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio in giant cell tumor of the extremities

  2019influential citation
• Tumor-Infiltrating Platelets Predict Postsurgical Survival in Patients with Pancreatic Ductal Adenocarcinoma

  2018cites this paper
• Pretreatment platelet count as a prognostic factor in patients with pancreatic cancer: a systematic review and meta-analysis

  2017cites this paper
• Pancreatic Exocrine Insufficiency in Pancreatic Cancer

  2017cites this paper